Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanisms in proliferative vitreoretinopathy.

Ivana K Kim1, Jorge G Arroyo

  • 1Department of Ophthalmology, Division of Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA.

Ophthalmology Clinics of North America
|June 18, 2002
PubMed
Summary

Proliferative vitreoretinopathy involves complex cellular interactions. Targeting multiple factors at various stages may improve patient outcomes for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of choroidal melanoma-associated exudative retinal detachments with a dexamethasone intravitreal implant prior to proton beam radiation.

Retinal cases & brief reports·2026
Same author

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Cancers·2026
Same author

Early genetic evolution of driver mutations in uveal melanoma.

Nature communications·2025
Same author

Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting.

JAMA ophthalmology·2025
Same author

Characterization of hydrolase activity in ocular tissues of humans and preclinical species.

Drug metabolism and disposition: the biological fate of chemicals·2025
Same author

Plasma and Urine Metabolites Associated with Microperimetric Retinal Sensitivity in Age-Related Macular Degeneration.

Metabolites·2025

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pathobiology

Background:

  • Proliferative vitreoretinopathy (PVP) is a significant cause of vision loss.
  • The wound-healing paradigm has been instrumental in understanding PVP pathobiology.

Purpose of the Study:

  • To elucidate the complex cellular and molecular mechanisms underlying PVP.
  • To evaluate the potential of multi-targeted therapeutic strategies for PVP.

Main Methods:

  • Review of current literature on PVP pathobiology.
  • Analysis of the roles of cytokines, matrix proteins, and metalloproteinases in PVP.
  • Conceptual framework for adjunctive therapeutic approaches.

Main Results:

  • PVP involves intricate interactions between cytokines, matrix proteins, and metalloproteinases.
  • These interactions influence cell behavior and lead to undesirable periretinal membrane formation.
  • A single-target therapy is unlikely to halt the cascade of events in PVP.

Conclusions:

  • Effective treatment of PVP likely requires a multi-pronged approach.
  • Targeting different stages of the disease cascade with adjunctive agents is a promising strategy.
  • Combined therapies may lead to improved visual outcomes for patients with PVP.

Related Experiment Videos